We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-16.31%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$359M
AUM Growth
-$86.9M
Cap. Flow
-$7.52M
Cap. Flow %
-2.09%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$4.84M
2
ALKS icon
Alkermes
ALKS
+$2.68M

Sector Composition

Rank Sector Weight
1 Healthcare 93.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$253M 70.43%
12,610,540
-231,258
-2% -$4.84M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$69.7M 19.39%
2,679,835
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$12.9M 3.58%
320,000
ALKS icon
4
Alkermes
ALKS
$8.82B
$12M 3.35%
603,790
-146,210
-19% -$2.68M
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$11.7M 3.25%
400,000

Similar funds

Meditor Group's Q4 2020 Portfolio in Review

As of Q4 2020, Meditor Group held 5 positions worth $359M, down 19% from $446M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 95% a quarter earlier.

  • Meditor Group's biggest Q4 2020 reduction was Exelixis, cutting an estimated $4.84M.
  • Meditor Group's ten largest holdings make up 100% of its $359M portfolio in Q4 2020.
  • Meditor Group opened 0 new positions and closed 0 in Q4 2020.
  • Meditor Group's portfolio value fell 19% quarter-over-quarter to $359M.

Based on Meditor Group's 13F filing for Q4 2020, filed 6 Jan 2021.